Pharmaceuticals - Leiden, Zuid-Holland, Netherlands
OcellO's mission is to help customer to discover the full potential of their compounds. OcellO offers in vitro assays which recapitulate and quantify complex human biology in a robust and high-throughput format. We test compounds for oncology, immuno-oncology, inflammation and cystopathy indications.We excel in in vitro 3D cell culture models and innovative high throughput imaging technologies. Our models are selected for clinically relevant, ‘near-vivo' properties and consist of patient-derived cells and patient-derived xenografts (PDX models) grown in 3D as organoids, tumoroids or microtissues. We offer a broad collection of human tissue models, including most solid tumor types, immune-oncology, cystopathies (incl. polycystic kidney disease and cystic fibrosis) and Inflammatory Bowel Disease. Functional read-outs are established by image analysis using OcellO's unique high throughput, high content screening platform. Features include cell proliferation, apoptosis, tumoroid size, organoid swelling, T cell infiltration, network formation, lumen formation and others. The high throughput format of our platform has proven ideal for in-depth functional profiling of a single compound or for screening of compound libraries in a single 3D disease model.OcellO would like to meet with companies (typically drug developers) that are interested in1. validation in 3D cell/organoid models of their drug candidate(s)2. screening services to discover new drug candidates in 3D cell modelsPlease visit our site at OcellO.nl for more information and contact.
Outlook
Hubspot
Salesforce
Sendgrid
Microsoft Office 365
Amazon AWS